Showing 1 - 7 results of 7 for search 'Cyrus Khandanpour', query time: 0.01s Refine Results
  1. 1
    A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma

    A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma by Alfred L. Garfall, Rahul Banerjee, Laurent Frenzel, Cyrus Khandanpour, Cyrus Khandanpour, Cyrus Khandanpour, Yi Lin, Erica Ottoni, Robert Rifkin, Sarah Rockwell, Cesar Rodriguez, Humberto Villefort, Elena Zamagni, Elena Zamagni

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab

    Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab by Lukas D. Uleer, Carmen Loquai, Iakov Shimanovich, Cyrus Khandanpour, Jasper N. Pruessmann, Patrick Terheyden, Christian D. Sadik

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Germline Single-Nucleotide Polymorphism <i>GFI1-36N</i> Causes Alterations in Mitochondrial Metabolism and Leads to Increased ROS-Mediated DNA Damage in a Murine Model of Human Acute Myeloid Leukemia

    Germline Single-Nucleotide Polymorphism <i>GFI1-36N</i> Causes Alterations in Mitochondrial Metabolism and Leads to Increased ROS-Mediated DNA Damage in a Murine Model of Human Acu... by Jan Vorwerk, Longlong Liu, Theresa Helene Stadler, Daria Frank, Helal Mohammed Mohammed Ahmed, Pradeep Kumar Patnana, Maxim Kebenko, Eva Dazert, Bertram Opalka, Nikolas von Bubnoff, Cyrus Khandanpour

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Functional Role of Fatty Acid Synthase for Signal Transduction in Core-Binding Factor Acute Myeloid Leukemia with an Activating c-Kit Mutation

    Functional Role of Fatty Acid Synthase for Signal Transduction in Core-Binding Factor Acute Myeloid Leukemia with an Activating c-Kit Mutation by Ruimeng Zhuang, Bente Siebels, Konstantin Hoffer, Anna Worthmann, Stefan Horn, Nikolas Christian Cornelius von Bubnoff, Cyrus Khandanpour, Niklas Gebauer, Sivahari Prasad Gorantla, Hanna Voss, Hartmut Schlüter, Malte Kriegs, Walter Fiedler, Carsten Bokemeyer, Manfred Jücker, Maxim Kebenko

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    AI-based body composition analysis of CT data has the potential to predict disease course in patients with multiple myeloma

    AI-based body composition analysis of CT data has the potential to predict disease course in patients with multiple myeloma by Franz Wegner, Malte Maria Sieren, Hanna Grasshoff, Lennart Berkel, Christoph Rowold, Marcel Philipp Röttgerding, Soleiman Khalil, Sam Mogadas, Felix Nensa, René Hosch, Gabriela Riemekasten, Anna Franziska Hamm, Nikolas von Bubnoff, Jörg Barkhausen, Roman Kloeckner, Cyrus Khandanpour, Theo Leitner

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

    Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnose... by Theo Leitner, Evgenii Shumilov, Christina Schwitlick, Raphael Koch, Franziska Hamm, Marion Högner, Florian Bassermann, Katja Weisel, Hermann Einsele, Martin Kortüm, Leo Rasche, Martin Görner, Kai Wegehenkel, Stefan Knop, Jan Krönke, Axel Nogai, Inke R. König, Maren Vens, Kay Horn, Nikolas von Bubnoff, Cyrus Khandanpour

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study

    Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study by Maximilian Merz, Anca‐Maria Albici, Bastian vonTresckow, Kristin Rathje, Roland Fenk, Tobias Holderried, Fabian Müller, Natalia Tovar, Aina Oliver‐Cáldes, Vladan Vucinic, Soraya Kharboutli, Ben‐Niklas Bärmann, Francis Ayuk, Uwe Platzbecker, Friedrich Stölzel, Nathalie Schub, Friederike Schmitz, David Fandrei, Patrick Born, Cyrus Khandanpour, Christine Hanoun, Keven Hörster, Marcel Teichert, Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Carlos Fernández de Larrea, Thomas Pabst, Nico Gagelmann

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: